陈兵

[摘要] 目的 对急性缺血性脑血管患者的临床效果进行观察和分析。方法 方便选取2015年1月—2016年6月期间该院收治的230例被确诊为急性缺血性脑血管疾病的患者为研究对象，并根据患者接受治疗的方将其分为观察组和对照组，其中实验组患者选择脑蛋白水解物、甲钴胺联合依达拉奉药物进行治疗，对照组予以奥拉西坦联合依达拉奉注射液药物治疗。对两组患者的生活自理能力、痊愈率以及神经功能的恢复情况进行观察和对比分析。 结果 在接受治疗后，观察组患者的生活自理能力评分要明显高于对照组[（50.23±16.10）分 vs （40.51±12.92）分]；观察组患者痊愈率（61.9%）明显高于对照组（25.7%），观察组患者治疗效果显著有效率（15.1%）明显低于对照组（29.5%），对照组患者有所好转情况（26.9%）明显好于观察组（12.5%），治疗后观察组患者的神经功能恢复和改善情况明显好于对照组（P<0.05）。 结论 与奥拉西坦联合依达拉奉治疗相比，运用脑蛋白水解物、甲钴胺联合依达拉奉药物治疗能够产生更加显著的效果，可在急性缺血性脑血管疾病治疗中进行临床应用和推广。

[关键词] 急性；缺血性脑血管疾病；临床效果

[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2017）08（a）-0113-03

[Abstracts] Objective This paper tries to observe and analyze the clinical effects of patients with acute ischemic cerebrovascular disease. Methods 230 patients diagnosed with acute ischemic cerebrovascular disease from January 2015 to June 2016 year in this hospital were convenient selected and divided into the observation group and control group according to the treatment methods， the observation group adopted hydrolysate， mecobalamin combined with edaravone drugs for the treatment. The control group was given oxiracetam combined with edaravone injection drug treatment. The self-care ability， the curative rate and the recovery of neurological function were observed and compared. Results After treatment， the observation group of patients with self-care ability score significantly higher than that of the control group[（50.23±16.10）points vs （40.51±12.92）points]； the cure rate in the observation group was 61.9%， significantly higher than the control group of 25.7%， the treatment efficiency in the observation group was 15.1%， significantly lower than the control group of 29.5%， the improvement of the control group was 26.9%， significantly better than the observation group of 12.5%， neurological function recovery and the improvement of the observation group of patients was significantly better than the control group（P<0.05）. Conclusion Compared with oxiracetam combined with edaravone treatment， the application of hydrolysate， mecobalamin combined with edaravone therapy can be more effective， and it is worth clinical application and promotion in the treatment of acute ischemic cerebrovascular disease.

[Key words] Acute ischemic； Cerebrovascular disease； Clinical effect

急性缺血性腦血管疾病是一种突发性的脑血管疾病，根据治病因素的差异，现主要分为血栓形成性和栓塞性共两大类别。该类疾病的产生会患者出现不同程度的脑缺血、脑梗塞症状，导致患者脑部出现损伤，严重的将威胁患者的生命[1-2]。为了进一步了解治疗急性缺血性脑血管疾病的临床效果，该文将以2015年1月—2016年6月期间该院收治的230例被确诊为急性缺血性脑血管疾病的患者为研究对象，对两组患者临床治疗效果进行对比和分析，现报道如下。……